Russell J. Butterfield, M.D., Ph.D. - Pediatrics - University of Utah

More documents

Recommendations

Info

2005 - 2010 Trainee, Children's Health Research Center (CHRC), UT2009 - 2011 Visiting Instructor, University of Utah, Salt Lake City, UT2011 - Present Assistant Professor, University of Utah, Salt Lake City, UTReviewer ExperienceReviewer for Annals of NeurologyReviewer for BMC Medical GeneticsReviewer for Epilepsy ResearchSCHOLASTIC HONORS1990 University Scholar, Brigham Young University, Provo, UT1994 - 1995 Lewis Medical Foundation Award1994 - 1995 University Scholar, Brigham Young University, Provo, UT1995 Phi Kappa Phi National Honor Society1995 Golden Key National Honor Society1998 Scholarship: Summer Institute of Statistical Genetics. North Carolina StateUniversity, Raleigh, NC1999 - 2000 University Fellowship for Academic Merit and Research Potential. Graduate CollageBlock Grant Fellowship Award, University of Illinois at Urbana-Champaign2002 Carle Frances and Charles Condit Fund Award. Medical Scholars Program,University of Illinois at Urbana- Champaign2005 - 2009 Primary Children’s Medical Center Foundation Scholar2009 Neurobiology of Disease in Children Symposium: Muscular Dystrophy, YoungInvestigator Award2010 World Muscle Society International Congress, Fellowship AwardADMINISTRATIVE EXPERIENCEAdministrative Duties2010 - Present Pediatric Neurology resident selection committee2012 - Present Co-director Muscular Dytrophy Association ClinicProfessional Organization & Scientific ActivitiesGrant Review Committee/Study Section2012 - Present Ad Hoc Reviewer, Muscular Dystrophy AssociationCURRENT MEMBERSHIPS IN PROFESSIONAL SOCIETIESChild Neurology SocietyWorld Muscle SocietyFUNDINGActive Grants01/01/09 -06/30/1301/01/10 -12/31/13Clinical and molecular characterization characterization of collagen VI myopathiesPrincipal Investigator: Russell J. ButterfieldNational Institutes of Health Loan Repayment ProgramRole: Principal InvestigatorGenotype-phenotype analysis of collagen VI myopathiesPrincipal Investigator: Russell J. ButterfieldDirect Costs: $50,000 Total Costs: $50,000Butterfield, Page 2
07/01/11 -06/30/1307/01/13 -06/30/14Primary Children's Medical Center FoundationRole: Principal InvestigatorChildren’s Health Research Center Development AwardGenetic and developmental mechanisms of pediatric diseasePrincipal Investigator: Edward B. ClarkNational Institute of Child Health and Human DevelopmentRole: K12 ScholarTranscriptome profiling for identification of biomarkers in congenital musculardystrophyPrincipal Investigator: Russell J. ButterfieldDirect Costs: $19,734 Total Costs: $19,734CureCMDRole: Principal InvestigatorPending Grants04/01/14 - Present Molecular pathogenesis of collagen VI myopathies--K08Principal Investigator: Russell J. ButterfieldDirect Costs: $613,750 Total Costs: $662,850National Institute of Child Health and Human DevelopmentRole: Principal InvestigatorPast Grants01/01/05 -06/30/1007/01/09 -06/30/11Identification of genes causing a novel form of autosomal juvenile recessiveamyotrophic lateral sclerosis. (Primary Children's Foundation)Children's Health Research CenterRole: TraineeNatural history and genetic epidemiology of collagen VI related myopathiesPrincipal Investigator(s): Russell J. Butterfield; Kevin M. Flanigan; Kathryn J.SwobodaDirect Costs: $173,500 Total Costs: $173,500Muscular Dystrophy AssociationRole: Principal InvestigatorActive Contracts10/26/10 - Present An Open-Label, Safety Study for Previously Treated Ataluren (PTC124) Patientswith Nonsense Mutation Dystrophinopathy (Protocol PTC124-GD-016-DMD)Principal Investigator: Russell J. ButterfieldPTC Therapeutics, Inc.Role: Principal Investigator04/01/13 - Present Duchenne Muscular Dystrophy: Double-Blind Randomized Trial to Find OptimumSteroid Regimen (FOR-DMD)Principal Investigator: Russell J. ButterfieldDirect Costs: $30,000 Total Costs: $44,850National Institute of Neurological Disorders and StrokeRole: PI04/01/13 - Present A Phase 3 Efficacy and Safety Study of Ataluren (PTC124) in Patients withNonsense Mutation Dystrophinopathy (PTC124-GD-020-DMD)Principal Investigator: Russell J. ButterfieldDirect Costs: $41,415 Total Costs: $54,957PTC Therapeutics, Inc.Role: Principal Investigator08/01/13 - Present A Randomized, Double-Blind, Placebo-Controlled, Phase 3Trial of Tadalafil forButterfield, Page 3
Page 1: Curriculum Vitae Last Updated: 08/1
Page 5 and 6: 2012 Research in Progress, Departme
Page 7: Local/Regional2007 A novel form of

Russell J. Butterfield, M.D., Ph.D. - Pediatrics - University of Utah

Create successful ePaper yourself

Delete template?

Save as template?